Hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions

Journal of Interferon and Cytokine Research

Volumn 25, Issue 6, 2005, Pages 297-310

  Hellwig Bürgel, Thomas ^a   Stiehl, Daniel P ^b   Wagner, Anika E ^a   Metzen, Eric ^a   Jelkmann, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANSAMYCIN DERIVATIVE; COLCHICINE; CYCLOOXYGENASE 2; GELDANAMYCIN; GLUCOCORTICOID; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NOCODAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; NOVOBIOCIN; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; RADICICOL; RAPAMYCIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VINBLASTINE; CYTOKINE; DNA BINDING PROTEIN; HIF1A PROTEIN, HUMAN; NUCLEAR PROTEIN;

BLOOD FLOW; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HYDROXYLATION; HYPOXIA; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; UBIQUITINATION; ANIMAL; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION FACTORS;

EID: 21344474796     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.297     Document Type: Review

References (166)

1. METZEN, E., and RATCLIFFE, P.J. (2004). HIF hydroxylation and cellular oxygen sensing. Biol. Chem. 385, 223-230.
2. BRACKEN, C.P., WHITELAW, M.L., and PEET, D.J. (2003). The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell. Mol. Life Sci. 60, 1376-1393.
3. SEMENZA, G.L., and WANG, G.L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
4. BECK, I., WEINMANN, R., and CARO, J. (1993). Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82, 704-711.
5. JELKMANN, W. (2004). Molecular biology of erythropoietin. Intern. Med. 43, 649-659.
6. FORSYTHE, J.A., JIANG, B.H., IYER, N.V., AGANI, F., LEUNG, S.W., KOOS, R.D., and SEMENZA, G.L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
7. KIMURA, H., WEISZ, A., OGURA, T., HITOMI, Y., KURASHIMA, Y., HASHIMOTO, K., D'ACQUISTO, F., MAKUUCHI, M., and ESUMI, H. (2001). Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 276, 2292-2298.
8. COULET, F., NADAUD, S., AGRAPART, M., and SOUBRIER, F. (2003). Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J. Biol. Chem. 278, 46230-46240.
9. LEE, P.J., JIANG, B.H., CHIN, B.Y., IYER, N.V., ALAM, J., SEMENZA, G.L., and CHOI, A.M. (1997). Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375-5381.
10. FERRARA, N., GERBER, H.P., and LECOUTER, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
11. FIRTH, J.D., EBERT, B.L., PUGH, C.W., and RATCLIFFE, P.J. (1994). Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. USA 91, 6496-6500.
12. SEMENZA, G.L., JIANG, B.H., LEUNG, S.W., PASSANTINO, R., CONCORDET, J.P., MAIRE, P., and GIALLONGO, A. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271, 32529-32537.
13. BEHROOZ, A., and ISMAIL-BEIGI, F. (1997). Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation. J. Biol. Chem. 272, 5555-5562.
14. GLEADLE, J.M., and RATCLIFFE, P.J. (1997). Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 89, 503-509.
15. 2-regulated gene expression. FASEB J. 16, 1151-1162.
16. HELLWIG-BÜRGEL, T., STIEHL, D.P., and JELKMANN, W. (2003). Hypoxia-inducible factor-1. In: Oxygen Sensing. S. Lahiri, G.L. Semenza, and N.R. Prabhakar (eds) New York: Marcel Dekker, Inc., pp 95-108.
17. BILTON, R.L., and BOOKER, G.W. (2003). The subtle side to hypoxia-inducible factor (HIFα) regulation. Eur. J. Biochem. 270, 791-798.
18. MELILLO, G., MUSSO, T., SICA, A., TAYLOR, L.S., COX, G.W., and VARESIO, L. (1995). A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693.
19. GRADIN, K., McGUIRE, J., WENGER, R.H., KVIETIKOVA, I., WHITELAW, M.L., TOFTGARD, R., TORA, L., GASSMANN, M., and POELLINGER, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the ARNT transcription factor. Mol. Cell. Biol. 16, 5221-5231.
20. WOOD, S.M., GLEADLE, J.M., PUGH, C.W., HANKINSON, O., and RATCLIFFE, P.J. (1996). The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J. Biol. Chem. 271, 15117-15123.
21. SCHMIDT, J.V., and BRADFIELD, C.A. (1996). Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
22. 2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
23. MINET, E., MOTTET, D., MICHEL, G., ROLAND, I., RAES, M., REMACLE, J., and MICHIELS, C. (1999). Hypoxia-induced activation of HIF-1: role of HIF-1 alpha-Hsp90 interaction. FEBS Lett. 460, 251-256.
24. ARANY, Z., HUANG, L.E., ECKNER, R., BHATTACHARYA, S., JIANG, C., GOLDBERG, M.A., BUNN, H.F., and LIVINGSTON, D.M. (1996). An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93, 12969-12973.
25. EBERT, B.L., and BUNN, H.F. (1998). Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor-1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell. Biol. 18, 4089-4096.
26. EMA, M., HIROTA, K., MIMURA, J., ABE, H., YODOI, J., SOGAWA, K., POELLINGER, L., and FUJII-KURIYAMA, Y. (1999). Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914.
27. SANG, N., FANG, J., SRINIVAS, V., LESHCHINSKY, I., and CARO, J. (2002). Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol. Cell. Biol. 22, 2984-2992.
28. MASSON, N., WILLAM, C., MAXWELL, P.H., PUGH, C.W., and RATCLIFFE, P.J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206.
29. 2-regulated prolyl hydroxylation. Science 292, 468-472.
30. 2 sensing. Science 292, 464-468.
31. EPSTEIN, A.C.R., GLEADLE, J.M., McNEILL, L.A., HEWITSON, K.S., O'ROURKE, J., MOLE, D.R., MUKHERJI, M., METZEN, E., WILSON, M.I., DHANDA, A., TIAN, Y.M., MASSON, N., HAMILTON, D.L., JAAKKOLA, P., BARSTEAD, R., HODGKIN, J., MAXWELL, P.H., PUGH, C.W., SCHOFIELD, C.J., and RATCLIFFE, P.J. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
32. BRUICK, R.K., and McKNIGHT, S.L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
33. HUANG, J., ZHAO, Q., MOONEY, S.M., and LEE, F.S. (2002). Sequence determinants in hypoxia inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 277, 39792-39800.
34. METZEN, E., BERCHNER-PFANNSCHMIDT, U., STENGEL, P., MARXSEN, J.H., STOLZE, I., KLINGER, M., HUANG, W.Q., WOTZLAW, C., HELLWIG-BUERGEL, T., JELKMANN, W., ACKER, H., and FANDREY, J. (2003). Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326.
35. OEHME, F., ELLINGHAUS, P., KOLKHOF, P., SMITH, T.J., RAMAKRISHNAN, S., HÜTTER, J., SCHRAMM, M., and FLAMME, I. (2002). Overexpresston of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343-349.
36. KNOWLES, H.J., RAVAL, R.R., HARRIS, A.L., and RATCLIFFE, P.J. (2003). Effect of ascorbate on the activity of hypoxia-inducible factor (HIF) in cancer cells. Cancer Res. 63, 1764-1768.
37. HIRSILÄ, M., KOIVUNEN, P., GÜNZLER, V., KIVIRIKKO, K.I., and MYLLYHARJU, J. (2003). Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772-30780.
38. MAXWELL, P.H., WIESENER, M.S., CHANG, G.W., CLIFFORD, S.C., VAUX, E.C., COCKMAN, M.E., WYKOFF, C.C., PUGH, C.W., MAHER, E.R., and RATCLIFFE, P.J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
39. OHH, M., PARK, C.W., IVAN, M., HOFFMAN, M.A., KIM, T.Y., HUANG, L.E., PAVLETICH, N., CHAU, V., and KAELIN, W.G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
40. SALCEDA, S., and CARO, J. (1997). Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647.
41. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992.
42. LANDO, D., PEET, D.J., GORMAN, J.J., WHELAN, D.A., WHITELAW, M.L., and BRUICK, R.K. (2002). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
43. DANN, C.E., BRUICK, R.K., and DEISENHOFER, J. (2002). Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway. Lancet 99, 15351-15356.
44. McNEILL, L.A., HEWITSON, K.S., CLARIDGE, T.D., SEIBEL, J.F., HORSFALL, L.E., and SCHOFIELD, C.J. (2002). Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem. J. 367, 571-575.
45. CAMENISCH, G., STROKA, D.M., GASSMANN, M., and WENGER, R.H. (2001). Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression. Eur. J. Physiol. 443, 240-249.
46. 2 levels. J. Cell Sci. 116, 3041-3049.
47. WANNER, R.M., SPIELMANN, P., STROKA, D.M., CAMENISCH, G., CAMENISCH, I., SCHEID, A., HOUCK, D.R., BAUER, C., GASSMANN, M., and WENGER, R.H. (2000). Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood 96, 1558-1565.
48. RAPISARDA, A., URANCHIMEG, B., SCUDIERO, D.A., SELBY, M., SAUSVILLE, E.A., SHOEMAKER, R.H., and MELILLO, G. (2002). Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62, 4316-4324.
49. IVAN, M., HABERBERGER, T., GERVASI, D.C., MICHELSON, K. S., GUNZLER, V., KONDO, K., YANG, H., SOROKINA, I., CONAWAY, R.C., CONAWAY, J.W., and KAELIN, W.-G.J. (2003). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464.
50. TIAN, H., McKNIGHT, S.L., and RUSSELL, D.W. (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72-82.
51. EMA, M., TAYA, S., YOKOTANI, N., SOGAWA, K., MATSUDA, Y., and FUJII, K.Y. (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor-1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 94, 4273-4278.
52. FLAMME, I., FROHLICH, T., VON-REUTERN, M., KAPPEL, A., DAMERT, A., and RISAU, W. (1997). HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels. Mech. Dev. 63, 51-60.
53. WIESENER, M.S., TURLEY, H., ALLEN, W.E., WILLAM, C., ECKARDT, K.U., TALKS, K.L., WOOD, S.M., GATTER, K.C., HARRIS, A.L., PUGH, C.W., RATCLIFFE, P.J., and MAXWELL, P.H. (1998). Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92, 2260-2268.
54. SCORTEGAGNA, M., MORRIS, M.A., OKTAY, Y., BENNETT, M., and GARCIA, J.A. (2003). The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 102, 1634-1640.
55. MAYNARD, M.A., QI, H., CHUNG, J., LEE, E.H., KONDO, Y., HARA, S., CONAWAY, R.C., CONAWAY, J.W., and OHH, M. (2003). Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278, 11032-11040.
56. HEIDBREDER, M., FRÖHLICH, F., JÖHREN, O., DENDORFER, A., QADRI, F., and DOMINIAK, P. (2003). Hypoxia rapidly activates HIF-3α mRNA expression. FASEB J. 17, 1541-1543.
57. MAKINO, Y., CAO, R., SVENSSON, K., BERTILSSON, G., ASMAN, M., TANAKA, H., CAO, Y., BERKENSTAM, A., and POELLINGER, L. (2001). Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554.
58. MAKING, Y., KANOPKA, A., WILSON, W.J., TANAKA, H., and POELLINGER, L. (2002). Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus. J. Biol. Chem. 277, 32405-32408.
59. WANG, G.L., JIANG, B.H., and SEMENZA, G.L. (1995). Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216, 669-675.
60. WYMANN, M.P., and PIROLA, L. (1998). Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436, 127-150.
61. VANHAESEBROECK, B., LEEVERS, S.J., AHMADI, K., TIMMS, J., KATSO, R., DRISCOLL, P.C., WOSCHOLSKI, R., PARKER, P.J., and WATERFIELD, M.D. (2001). Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535-602.
62. STOYANOV, B., VOLINIA, S., HANCK, T., RUBIO, I., LOUBTCHENKOV, M., MALEK, D., STOYANOVA, S., VANHAESEBROECK, B., DHAND, R., and NURNBERG, B. (1995). Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269, 690-693.
63. SODHI, A., MONTANER, S., MIYAZAKI, H., and GUTKIND, J.S. (2001). MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1α in rasV12 upregulation of VEGF. Biochem. Biophys. Res. Commun. 287, 292-300.
64. ZHONG, H., CHILES, K., FELDSER, D., LAUGHNER, E., HANRAHAN, C., GEORGESCU, M.M., SIMONS, J.W., and SEMENZA, G.L. (2000). Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.
65. CHAN, D.A., SUTPHIN, P.D., DENKO, N.C., and GIACCIA, A.J. (2003). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α J. Biol. Chem. 277, 40112-40117.
66. ALVAREZ-TEJADO, M., ALFRANCA, A., ARAGONÉS, J., VARA, A., LANDAZURI, M.O., and DEL PESO, L. (2002). Lack of evidence for the involvement of the phoshoinositide 3-kinase/akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J..Biol. Chem. 277, 13508-13517.
67. ARSHAM, A.M., PLAS, D.R., THOMPSON, C.B., and SIMON, M.C. (2002). Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277, 15162-15170.
68. ZELZER, E., LEVY, Y., KAHANA, C., SHILO, B.Z., RUBINSTEIN, M., and COHEN, B. (1998). Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17, 5085-5094.
69. FELDSER, D., AGANI, F., IYER, N.V., PAK, B., FERREIRA, G., and SEMENZA, G.L. (1999). Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res. 59, 3915-3918.
70. JIANG, B.H., JIANG, G., ZHENG, J.Z., LU, Z., HUNTER, T., and VOGT, P.K. (2001). Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363-369.
71. STIEHL, D.P., JELKMANN, W., WENGER, R.H., and HELLWIG-BÜRGEL, T. (2002). Normoxic induction of the hypoxia-inducible factor-1α by insulin and interleukin-1/3 involves the Phosphatidylinositol 3-kinase pathway. FEES Lett. 512, 157-162.
72. FUKUDA, R., HIROTA, K., FAN, F., JUNG, Y.D., ELLIS, L.M., and SEMENZA, G.L. (2002). Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205-38211.
73. LAUGHNER, E., TAGHAVI, P., CHILES, K., MAHON, P.C., and SEMENZA, G.L. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor-1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004.
74. TREINS, C., GIORGETTI-PERALDI, S., MURDACA, J., SEMENZA, G.L., and VAN OBBERGHEN, E. (2002). Insulin stimulates hypoxia-inducible factor-1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277, 27975-27981.
75. CANTLEY, L.C., and NEEL, B.C. (1999). New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96, 4240-4245.
76. ZUNDEL, W., SCHINDLER, C., HAAS, K.D., KOONG, A., KAPER, F., CHEN, E., GOTTSCHALK, A.R., RYAN, H.E., JOHNSON, R.S., JEFFERSON, A.B., STOKOE, D., and GIACCIA, A.J. (2000). Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391-396.
77. JIANG, B.H., ZHENG, J.Z., AOKI, M., and VOGT, P.K. (2000). Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97, 1749-1753.
78. SANDAU, K.B., ZHOU, J., KIETZMANN, T., and BRUNE, B. (2001). Regulation of the hypoxia-inducible factor-1α by the inflammatory mediators nitric oxide and tumor necrosis factor-1α in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276, 39805-39811.
79. MAZURE, N.M., CHEN, E.Y., LADEROUTE, K.R., and GIACCIA, A.J. (1997). Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90, 3322-3331.
80. ZHOU, J., SCHMID, T., FRANK, R., and BRUNE, B. (2004). PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor-1alpha from pVHL-independent degradation. J. Biol. Chem. 279, 13506-13513.
81. RICHARD, D.E., BERRA, E., GOTHIE, E., ROUX, D., and POUYSSEGUR, J. (1999). p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor-1a (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274, 32631-32637.
82. MINET, E., ARNOULD, T., MICHEL, G., ROLAND, I., MOTTET, D., RAES, M., REMACLE, J., and MICHIELS, C. (2000). ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468, 53-58.
83. HUR, E., CHANG, K.Y., LEE, E., LEE, S.-K., and PARK, H. (2001). Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1α. Mol. Pharmacol. 59, 1216-1224.
84. SODHI, A., MONTANER, S., PATEL, V., ZOHAR, M., BAIS, C., MESRI, E.A., and GUTKIND, J.S. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor-1alpha. Cancer Res. 60, 4873-4880.
85. SANG, N., STIEHL, D.P., BOHENSKY, J., LESHCHINSKY, I., SRINIVAS, V., and CARO, J. (2003). Mitogen-activated protein kinase (MAPK) signaling upregulates the activity of hypoxia inducible factors by its effects on p300. J. Biol. Chem. 278, 14013-14019.
86. GUSTERSON, R., BRAR, B., FAULKES, D., GIORDANO, A., CHRIVIA, J., and LATCHMAN, D. (2002). The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade. J. Biol. Chem. 277, 2517-2524.
87. GRADIN, K., TAKASAKI, C., FUJII-KURIYAMA, Y., and SOGAWA, K. (2002). The transcriptional activation function of the HIF-like factor requires phosphorylation at a conserved thre-onine. J. Biol. Chem. 277, 23508-23514.
88. ARAGONÉS, J., JONES, D.R., MARTÍN, S., SAN JUAN, M.A., ALFRANCA, A., VIDA, F., VARA, A., MÉRIDA, I., and LANDÁZURI, M.O. (2001). Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension. J. Biol. Chem. 276, 10548-10555.
89. BAEK, S.H., LEE, U.Y., PARK, E.M., HAN, M.Y., LEE, Y.S., and PARK, Y.M. (2001). Role of protein kinase CS in transmitting hypoxia signal to HSF and HIF-1. J. Cell. Physiol. 188, 223-235.
90. HELLWIG-BÜRGEL, T., RUTKOWSKI, K., METZEN, E., FANDREY, J., and JELKMANN, W. (1999). Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567.
91. EL AWAD, B., KREFT, B., WOLBER, E.-M., HELLWIG-BÜRGEL, T., METZEN, E., FANDREY, J., and JELKMANN, W. (2000). Hypoxia and interleukin-1β stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int. 58, 43-50.
92. THORNTHON, R.D., LANE, P., BORGHAEI, R.C., PEASE, E.A., CARO, J., and MOCHAN, E. (2000). Interleukin-1 induces hypoxia-inducible factor-1 in human gingival and synovial fibroblasts. Biochem. J. 350, 307-312.
93. ALBINA, J.E., MASTROFRANCESCO, B., VESSELLA, J.A., LOUIS, C.A., HENRY, W.L., Jr., and REICHNER, J.S. (2001). HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am. J. Physiol. Cell Physiol. 281, C1971-C1977.
94. SCHARTE, M., HAN, X., BERTGES, D.J., FINK, M. P., and DELUDE, R.L. (2003). Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G373-G384.
95. JUNG, Y.J., ISAACS, J.S., SUNMIN, L., TREPEL, J., and NECKERS, L. (2003). IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17, 2115-2117.
96. HELLWIG-BÜRGEL, T., STIEHL, D.P., KATSCHINSKI, D., MARXSEN, J.H., KREFT, B., and JELKMANN, W. (2005). VEGF production by primary human renal proximal tubular cells: requirement of HIF-1, PI3-kinase and MAPKK-1 signaling. Cell. Physiol. Biochem. 15, 99-108.
97. JUNG, Y., ISAACS, J.S., LEE, S., TREPEL, J., LIU, Z.G., and NECKERS, L. (2003). Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem. J. 370, 1011-1017.
98. REDDY, S.A., HUANG, J.H., and LIAO, W.S. (2000). Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J. Immunol. 164, 1355-1363.
99. ZHOU, J., SCHMID, T., and BRUNE, B. (2003). Tumor necrosis factor-α causes accumulation of a ubiquitinated form of hypoxia inducible factor-1α through a nuclear factor-κB-dependent pathway. Mol. Biol. Cell 14, 2216-2225.
100. HADDAD, J.J., and LAND, S.C. (2001). A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett. 505, 269-274.
101. FANDREY, J., and GENIUS, J. (2000). Reactive oxygen species as regulators of oxygen-dependent gene expression. Adv. Exp. Med. Biol. 475, 153-159.
102. BLOUIN, C.C., PAGE, E.L., SOUCY, G.M., and RICHARD, D.E. (2004). Hypoxic gene activation by lipopolysacchartde in macrophages: implication of hypoxia-inducible factor-1 alpha. Blood 103, 1124-1130.
103. SHIH, S.C., and CLAFFEY, K.P. (2001). Role of AP-1 and HIF-1 transcription factors in TGF-β activation of VEGF expression. Growth Factors 19, 19-34.
104. phox-containing NADPH oxidase. Circ. Res. 89, 47-54.
105. CANIGGIA, I., MOSTACHFI, H., WINTER, J., GASSMANN, M., LYE, S.J., KULISZEWSKI, M., and POST, M. (2000). Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3. J. Clin. Invest. 105, 577-587.
106. SCHAFFER, L., SCHEID, A., SPIELMANN, P., BREYMANN, C., ZIMMERMANN, R., MEULI, M., GASSMANN, M., MARTI, H.H., and WENGER, R.H. (2003). Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta 24, 941-950.
107. SANCHEZ-ELSNER, T., BOTELLA, L.M., VELASCO, B., CORBI, A., ATTISANO, L., and BERNABEU, C. (2001). Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276, 38527-38535.
108. LADEROUT, K.R., CALAOAGAN, J.M., GUSTAFSON-BROWN, C., KNAPP, A.M., LI, G.-C., MENDONCA, H.L., RYAN, H.E., WANG, Z., and JOHNSON, R.S. (2002). The response of c-Jun/AP-1 to chronic hypoxia is hypoxia-inducible factor-1α dependent. Mol. Cell. Biol. 22, 2515-2523.
109. BURGESS, T.L., ROSS, S.L., QIAN, Y.X., BRANKOW, D., and HU, S. (1995). Biosynthetic processing of neu differentiation factor. Glycosylation trafficking, and regulated cleavage from the cell surface. J. Biol. Chem. 270, 19188-19196.
110. MAITY, A., PORE, N., LEE, J., SOLOMON, D., and O'ROURKE, D.M. (2000). Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia. Cancer Res. 60, 5879-5886.
111. RICHARD, D.E., BERRA, E., and POUYSSEGUR, J. (2000). Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J. Biol. Chem. 275, 26765-26771.
112. TACCHINI, L., DANSl, P., MATTEUCCI, E., and DESIDERIO, M.A. (2001). Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22, 1363-1371.
113. MORRIS, S.M., and BILLIAR, T.R. (1994). New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266, E829-E839.
114. SOGAWA, K., NUMAYAMA-TSURUTA, K., EMA, M., ABE, M., ABE, H., and FUJII-KURIYAMA, Y. (1998). Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc. Natl. Acad. Sci. USA 95, 7368-7373.
115. LIU, Y., CHRISTOU, H., MORITA, T., LAUGHNER, E., SEMENZA, G.L., and KOUREMBANAS, S. (1998). Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J. Biol. Chem. 273, 15257-15262.
116. HUANG, L.E., WILLMORE, W.G., GU, J., GOLDBERG, M.A., and BUNN, H.F. (1999). Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J. Biol. Chem. 274, 9038-9044.
117. PALMER, L.A., GASTON, B., and JOHNS, R.A. (2000). Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol. Pharmacol. 58, 1197-1203.
118. NATARAJAN, R., FISHER, B.J., and FOWLER, A.A., III. (2003). Regulation of hypoxia inducible factor-1 by nitric oxide in contrast to hypoxia in microvascular endothelium. FEBS Lett. 549, 99-104.
119. GENIUS, J., and FANDREY, J. (2000). Nitric oxide affects the production of reactive oxygen species in hepatoma cells: implications for the process of oxygen sensing. Free Radic. Biol. Med. 29, 515-521.
120. BRÜNE, B., and ZHOU, J. (2003). The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1 alpha (HIF-1alpha). Curr. Med. Chem. 10, 845-855.
121. SANDAU, K.B., FANDREY, J., and BRUNE, B. (2001). Accumulation of HIF-1α under the influence of nitric oxide. Blood 97, 1009-1015.
122. MATEO, J., GARCIA-LECEA, M., CADENAS, S., HERNANDEZ, C., and MONCADA, S. (2003). Regulation of hypoxia-inducible factor-1α by nitric oxide through mitochondria-dependent and -independent pathways. Biochem. J. 376, 537-544.
123. KASUNO, K., TAKABUCHI, S., FUKUDA, K., KIZAKA-KONDOH, S., YODOI, J., ADACHI, T., SEMENZA, G.L., and HIROTA, K. (2004). Nitric oxide induces hypoxia-inducible factor-1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J. Biol. Chem. 279, 2550-2558.
124. METZEN, E., ZHOU, J., JELKMANN, W., FANDREY, J., and BRÜNE, B. (2003). Nitric oxide impairs normoxic degradation of HIF-Ia by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14, 3470-3481.
125. WANG, F., SEKINE, H., KIKUCHI, Y., TAKASAKI, C., MIURA, C., HEIWA, O., SHUIN, T., FUJII-KURIYAMA, Y., and SOGAWA, K. (2002). HIF-1α-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway. Biochem. Biophys. Res. Commun. 295, 657-662.
126. HAGEN, T., TAYLOR, C.T., LAM, F., and MONCADA, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF-1α. Science 302, 1975-1978.
127. BRÜNE, B., MOHR, S., and MESSMER, U.K. (1996). Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev. Physiol. Biochem. Pharmacol. 127, 1-30.
128. SUMBAYEV, V.V., BUDDE, A., ZHOU, J., and BRÜNE, B. (2003). HIF-1α protein as a target for S-nitrosation. FEBS Lett. 535, 106-112.
129. YASINSKA, I.M., and SUMBAYEV, V.V. (2003). S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEES Lett. 549, 105-109.
130. CRAMER, T., YAMANISHI, Y., CLAUSEN, B.E., FORSTER, I., PAWLINSKI, R., MACKMAN, N., HAASE, V.H., JAENISCH, R., CORR, M., NIZET, V., FIRESTEIN, G.S., GERBER, H.P., FERRARA, N., and JOHNSON, R.S. (2003). HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
131. MELILLO, G., TAYLOR, L.S., BROOKS, A., MUSSO, T., COX, G.W., and VARESIO, L. (1997). Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272, 12236-12243.
132. RYAN, H.E., LO, J., and JOHNSON, R.S. (1998). HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005-3015.
133. KOJIMA, H., GU, H., NOMURA, S., CALDWELL, C.C., KOBATA, T., CARMELIET, P., SEMENZA, G.L., and SITKOVSKY, M.V. (2002). Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc. Natl. Acad. Sci. USA 99, 2170-2174.
134. BIJU, M.P., NEUMANN, A.K., BENSINGER, S.J., JOHNSON, R.S., TURKA, L.A., and HAASE, V.H. (2004). Vhlh gene deletion induces HIF-1-mediated cell death in thymocytes. Mol. Cell. Biol. 24, 9038-9047.
135. MACKOWIAK, P.A. (1998). Concepts of fever. Arch. Intern. Med. 158, 1870-1881.
136. KATSCHINSKI, D.M., LE, L., HEINRICH, D., WAGNER K.F., HOFER, T., SCHINDLER, S.G., and WENGER, R.H. (2002). Heat induction of the unphosphorylated form of hypoxia-inducible factor-1α is dependent on heat shock protein-90 activity. J. Biol. Chem. 277, 9262-9267.
137. SUZUKI, H., TOMIDA, A., and TSURUO, T. (2001). Dephosphorylated hypoxia-inducible factor-1α as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 20, 5779-5788.
138. SCHEIBEL, T., and BUCHNER, J. (1998). The Hsp90 complex - a superchaperone machine as a novel drug target. Biochem. Pharmacol. 56, 675-682.
139. SCHULTE, T.W., AKINAGA, S., MURAKATA, T., AGATSUMA, T., SUGIMOTO, S., NAKANO, H., LEE, Y. S., SIMEN, B.B., ARGON, Y., FELTS, S., TOFT, D.O., NECKERS, L.M., and SHARMA, S.V. (1999). Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones. Mol. Endocrinol. 13, 1435-1448.
140. ISAACS, J.S., JUNG, Y.J., and NECKERS, L. (2004). Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway. J. Biol. Chem. 279, 16128-16135.
141. KUREBAYASHI, J., OTSUKI, T., KUROSUMI, M., SOGA, S., AKINAGA, S., and SONOO, H. (2001). A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts. Jpn. J. Cancer Res. 92, 1342-1351.
142. HUR, E., KIM, H.H., CHOI, S.M., KIM, J.H., YIM, S., KWON, H.J., CHOI, Y., KIM, D.K., LEE, M.O., and PARK, H. (2002). Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol. Mol. Pharmacol. 62, 975-982.
143. ISAACS, J.S., JUNG, Y.J., MIMNAUGH, E.G., MARTINEZ, A., CUTTITTA, F., and NECKERS, L.M. (2002). Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway. J. Biol. Chem. 277, 29936-29944.
144. KATSCHINSKI, D., LE, L., SCHINDLER, S., THOMAS, T., VOSS, A., and WENGER, R. (2004). Interaction of the PAS B domain with HSP 90 accelerates hypoxia-inducible factor-1 alpha stabilization. Cell. Physiol. Biochem. 14, 351-360.
145. ZHANG, S.X., GOZAL, D., SACHLEBEN, L.R., Jr., RANE, M., KLEIN, J.B., and GOZAL, E. (2003). Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. FASEB J. 17, 1709-1711.
146. ELSON, D.A., THURSTON, G., HUANG, L.E., GINZINGER, D.G., McDONALD, D.M., JOHNSON, R.S., and ARBEIT, J.M. (2001). Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes Dev. 15, 2520-2532.
147. HOLLANDER, A.P., CORKE, K.P., FREEMONT, A.J., and LEWIS, C.E. (2001). Expression of hypoxia-inducible factor-1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540-1544.
148. SCHEID, A., WENGER, R.H., SCHAFFER, L., CAMENISCH, I., DISTLER, O., FERENC, A., CRISTINA, H., RYAN, H.E., JOHNSON, R., WAGNER, K.F., STAUFFER, U.G., BAUER, C., GASSMANN, M., and MEULI, M. (2002). Physiologically low oxygen concentrations determined in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-β3. FASEB J. 16, 411-413.
149. GIACCIA, A., SIIM, B.G., and JOHNSON, R.S. (2003). HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2, 803-811.
150. JUNG, Y.J., ISAACS, J.S., LEE, S., TREPEL, J., and NECKERS, L. (2003). Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1 alpha protein. J. Biol. Chem. 278, 7445-7452.
151. NEMOTO, T., MASON, G.G., WILHELMSSON, A., CUTHILL, S., HAPGOOD, J., GUSTAFSSON, J.A., and POELLINGER, L. (1990). Activation of the dioxin and glucocorticoid receptors to a DNA binding state under cell-free conditions. J. Biol. Chem. 265, 2269-2277.
152. CATO, A.C., and WADE, E. (1996). Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18, 371-378.
153. KODAMA, T., SHIMIZU, N., YOSHIKAWA, N., MAKING, Y., OUCHIDA, R., OKAMOTO, K., HISADA, T., NAKAMURA, H., MORIMOTO, C., and TANAKA, H. (2003). Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J. Biol. Chem. 278, 33384-33391.
154. HELLWIG-BUERGEL, T., WAGNER, A., and JELKMANN, W. (2004). Glucocorticoids impair hypoxia-inducible factor 1 (HIF-1) function. Keystone Symposia, Biology of Hypoxia: The Role of Oxygen Sensing in Development, Normal Function and Disease. Abstract No. 203.
155. WAGNER, A., HELLWIG-BUERGEL, T., and JELKMANN, W. (2004). Normoxic induced hypoxia-inducible factor-1α (HIF-1α) is negatively affected by glucocorticoids. Keystone Symposia, Biology of Hypoxia: The Role of Oxygen Sensing in Development, Normal Function and Disease. Abstract No. 349.
156. BUREN, I., LIU, H.X., JENSEN, I., and ERIKSSON, J.W. (2002). Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur. J. Endocrinol. 146, 419-429.
157. COMBARET, L., TAILLANDIER, D., DARDEVET, D., BECHET, D., RALLIERE, C., CLAUSTRE, A., GRIZARD, I., and ATTAlX, D. (2004). Glucocorticoids regulate mRNA levels for subunits of the 19S regulatory complex of the 26S proteasome in fast-twitch skeletal muscles. Biochem. J. 378, 239-246.
158. KLEKAMP, J.G., JARZECKA, K., HOOVER, R.L., SUMMAR, M.L., REDMOND, N., and PERKETT, E.A. (1997). Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr. Res. 42, 744-749.
159. HEISS, J.D., PAPAVASSILIOU, E., MERRILL, M.I., NIEMAN, L., KNIGHTLY, J.J., WALBRIDGE, S., EDWARDS, N.A., and OLDFIELD, E.H. (1996). Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J. Clin. Invest. 98, 1400-1408.
160. NAUCK, M., ROTH, M., TAMM, M., EICKELBERG, O., WIELAND, H., STULZ, P., and PERRUCHOUD, A.P. (1997). Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am. J. Respir. Cell. Mol. Biol. 16, 398-406.
161. DERAMAUDT, T.B., DA SILVA, J.L., REMY, P., KAPPAS, A., and ABRAHAM, N.G. (1999). Negative regulation of human heme oxygenase in microvessel endothelial cells by dexamethasone. Proc. Soc. Exp. Biol. Med 222, 185-193.
162. WHITWORTH, J.A., SCHYVENS, C.G., ZHANG, Y., ANDREWS, M.C., MANGOS, G.J., and KELLY, J.J. (2002). The nitric oxide system in glucocorticoid-induced hypertension. J. Hypertens. 20, 1035-1043.
163. ZHONG, H., DE MARZO, A.M., LAUGHNER, E., LIM, M., HILTON, D.A., ZAGZAG, D., BUECHLER, P., ISAACS, W.B., SEMENZA, G.L., and SIMONS, J.W. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835.
164. GARAYOA, M., MARTINEZ, A., LEE, S., PIO, R., AN, W.G., NECKERS, L., TREPEL, J., MONTUENGA, L.M., RYAN, H., JOHNSON, R., GASSMANN, M., and CUTTITTA, F. (2000). Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14, 848-862.
165. HOPFL, G., OGUNSHOLA, O., and GASSMANN, M. (2004). HIFs and tumors - causes and consequences. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R608-R623.
166. JONES, M.K., SZABO, I.L., KAWANAKA, H., HUSAIN, S.S., and TARNAWSKJ, A.S. (2002). von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 16, 264-266.